Evidence map›Paper›PMID 37083961›Full record

ArticleGlycobiology2023

BiotechLec: an interactive guide of commercial lectins for glycobiology and biomedical research applications.

Boris Schnider, Francisco L Escudero, Anne Imberty, Frédérique Lisacek

Abstract read
In one paragraph

Article in Glycobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. A Boltzmann model predicts glycan structures from lectin binding.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Sensitive and Specific Global Cell SurfaceAnalytical chemistry · 2023
    Article
  7. Influence of maternal rats' hypothyroidism on morpho-functional peculiarities and glycome of progeny skin.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Boris SchniderProteome Informatics Group, SIB Swiss Institute of Bioinformatics, route de Drize 7, Geneva CH-1227, Switzerland.
Francisco L EscuderoProteome Informatics Group, SIB Swiss Institute of Bioinformatics, route de Drize 7, Geneva CH-1227, Switzerland.
Anne ImbertyUniversity Grenoble Alpes, CNRS, CERMAV, 601 rue de la chimie, Grenoble 38000, France.
Frédérique LisacekProteome Informatics Group, SIB Swiss Institute of Bioinformatics, route de Drize 7, Geneva CH-1227, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For decades, lectins have been used as probes in glycobiology and this usage has gradually spread to other domains of Life Science. Nowadays, researchers investigate glycan recognition with lectins in diverse biotechnology and clinical applications, addressing key questions regarding binding specificity. The latter is documented in scattered and heterogeneous sources, and this situation calls for a centralized and easy-access reference. To address this need, an on-line solution called BiotechLec (https://www.unilectin.eu/biotechlec) is proposed in a new section of UniLectin, a platform dedicated to lectin molecular knowledge.

Indexed as

Biomedical ResearchLectinsBiotechnologyGlycomicsPolysaccharidesLectinsPolysaccharidesbiotechnologycarbohydrate-bindingdatabaseglycosylationlectins

Identifiers

PMID37083961
PMCPMC10627245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.